InvestSMART
  1. Home
  2. Research & Advice
  3. Research Tools
  4. Shares
  5. WCM Quality Global Growth Fund (Managed Fund) (WCMQ)
  6. Fund details

WCM Quality Global Growth Fund (Managed Fund) (ASX: WCMQ) - Share Price and Research

Current share price for WCMQ : $8.880 0.06 (0.67%)

WCM Quality Global Growth Fund (Quoted Managed Fund) (WCMQ) provides investors with access to an actively managed portfolio of quality global companies found primarily in the high growth consumer, technology and healthcare sectors.

General Information

WCM Quality Global Growth ETF (Quoted Mgd)
Equity World Large Growth
MSCI World Ex Australia NR AUD
starstarstarstar (as at 31 Mar 2024)
Investment Fund
31 Aug 2018
$348.89 million (as at 16 Apr 2024)
$7.7 (as at 30 Aug 2023)
$7.33 (as at 30 Aug 2023)

Fund performance (31 Mar 2024)

NOTE : returns for periods greater than 1 year are annualised
  1 Month % 3 Month % 6 Month % 1 Year % p.a. 2 Year % p.a. 3 Year % p.a. 5 Year % p.a. 10 Year % p.a.
Total return 3.22 20.11 29.01 35 17.29 9.85 14.03 -
Growth return 3.22 20.11 29.01 35 13.65 7.56 11.88 -
Income return 0 0 0 0 3.64 2.29 2.15 -

Market index (MSCI World Ex Australia NR AUD)
Total return 3.02 14.06 20.11 28.72 15.87 14.43 - 13.43

Asset Allocation (31 Mar 2024)

Australian Equities 0%
International Equities 97.91%
Cash 2.09%
Property 0%
Fixed Interest 0%
Alternatives 0%
Asset Allocation

Objectives and Strategy

The performance objective of the Fund is to exceed its benchmark, the MSCI All Country World Index ex-Australia (with gross dividends reinvested reported in Australian dollars and unhedged) (the Benchmark) before tax and fees over rolling three-year time periods, but with lower volatility than the Benchmark. The suggested investment timeframe is for a minimum of five years.
The performance objective of the Fund is to exceed its benchmark, the MSCI All Country World Index ex-Australia (with gross dividends reinvested reported in Australian dollars and unhedged) (the Benchmark) before tax and fees over rolling three-year time periods, but with lower volatility than the Benchmark.

Offer information

Indirect Cost Ratio (ICR) 1.35% (as at 30 Jun 2023)
Performance fee (not included in ICR) 0
Minimum initial investment $500.00

Top 10 holdings (as at 30 Sep 2023)

Holding Type % of Portfolio
Novo Nordisk A/S Class B Equity 4.66%
Login now to view the complete list of holdings.

Fund data sourced from Morningstar. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only. Whilst every care has been taken in producing these numbers, neither Morningstar nor InvestSMART can make any guarantees around the complete accuracy of these figures. Should you decide to change investments, please read all relevant disclosure documents including the Product Disclosure Statements and if required, you may consider speaking to a financial professional for further guidance. A tax event may be realised as a result of switching investments. Past performance is not a reliable indicator of future performance.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.